Is Genotype 3 of the Hepatitis C Virus the New Villain?

被引：113

作者：

Goossens, Nicolas ^{[1
]}

Negro, Francesco ^{[1
,2
]}

机构：

[1] Univ Hosp Geneva, Div Gastroenterol & Hepatol, CH-1211 Geneva 4, Switzerland

[2] Univ Hosp Geneva, Div Clin Pathol, CH-1211 Geneva 4, Switzerland

来源：

HEPATOLOGY | 2014年 / 59卷 / 06期

基金：

瑞士国家科学基金会;

关键词：

SUSTAINED VIROLOGICAL RESPONSE; TRIGLYCERIDE TRANSFER PROTEIN; ACTIVATED-RECEPTOR-ALPHA; TREATMENT-NAIVE PATIENTS; HEPATOCELLULAR-CARCINOMA; PLUS RIBAVIRIN; HCV GENOTYPE; PEGINTERFERON ALPHA-2B; RISK-FACTOR; CHOLESTEROL-METABOLISM;

D O I：

10.1002/hep.26905

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Genotype 3 of the hepatitis C virus (HCV) has been long considered an easy-to-treat infection, with higher cure rates (similar to 70%) than other viral genotypes with the standard combination of pegylated interferon-alpha and ribavirin. However, the relative insensitivity of this genotype to most protease inhibitors and the recent unexpected data on decreased effectiveness of sofosbuvir have raised questions on how to achieve universal cure, a goal that seems reasonable for other genotypes. In addition, increasing clinical and experimental data show that HCV genotype 3 may be associated not only with severe steatosis, but also with accelerated fibrosis progression rate and increased oncogenesis. Conclusion: Currently available data suggest that we should increase our efforts to understand the virology and pathogenesis of HCV genotype 3, aiming at better and more potent, genotype-targeted treatments.

引用

页码：2403 / 2412

页数：10

共 74 条

[31] Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection [J].

Jacobson, Ira M. ;

McHutchison, John G. ;

Dusheiko, Geoffrey ;

Di Bisceglie, Adrian M. ;

Reddy, K. Rajender ;

Bzowej, Natalie H. ;

Marcellin, Patrick ;

Muir, Andrew J. ;

Ferenci, Peter ;

Flisiak, Robert ;

George, Jacob ;

Rizzetto, Mario ;

Shouval, Daniel ;

Sola, Ricard ;

Terg, Ruben A. ;

Yoshida, Eric M. ;

Adda, Nathalie ;

Bengtsson, Leif ;

Sankoh, Abdul J. ;

Kieffer, Tara L. ;

George, Shelley ;

Kauffman, Robert S. ;

Zeuzem, Stefan .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25) :2405-2416

[32] Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response [J].

Kumar, D ;

Farrell, GC ;

Fung, C ;

George, J .

HEPATOLOGY, 2002, 36 (05) :1266-1272

[33] PSI-7851, a Pronucleotide of β-D-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication [J].

Lam, Angela M. ;

Murakami, Eisuke ;

Espiritu, Christine ;

Steuer, Holly M. Micolochick ;

Niu, Congrong ;

Keilman, Meg ;

Bao, Haiying ;

Zennou, Veronique ;

Bourne, Nigel ;

Julander, Justin G. ;

Morrey, John D. ;

Smee, Donald F. ;

Frick, David N. ;

Heck, Julie A. ;

Wang, Peiyuan ;

Nagarathnam, Dhanapalan ;

Ross, Bruce S. ;

Sofia, Michael J. ;

Otto, Michael J. ;

Furman, Phillip A. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (08) :3187-3196

[34] Hepatitis C Virus Genotype 3 and the Risk of Severe Liver Disease in a Large Population of Drug Users in France [J].

Larsen, Christine ;

Bousquet, Vanina ;

Delarocque-Astagneau, Elisabeth ;

Pioche, Corinne ;

Roudot-Thoraval, Francoise ;

Desenclos, Jean-Claude .

JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (10) :1647-1654

[35]

Lawitz E, 2013, NEW ENGL J MED, V369, P678, DOI [10.1056/NEJMoa1214853, 10.1056/NEJMc1307641]

[36] Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data [J].

Leandro, Gioacchino ;

Mangia, Alessandra ;

Hui, Jason ;

Fabris, Paolo ;

Rubbia-Brandt, Laura ;

Colloredo, Guido ;

Adinolfi, Luigi E. ;

Asselah, Tarik ;

Jonsson, Julie R. ;

Smedile, Antonina ;

Terrault, Norah ;

Pazienza, Valerio ;

Giordani, Maria Teresa ;

Giostra, Emiliano ;

Sonzogni, Aurelio ;

Ruggiero, Giuseppe ;

Marcellin, Patrick ;

Powell, Elizabeth E. ;

George, Jacob ;

Negro, Francesco .

GASTROENTEROLOGY, 2006, 130 (06) :1636-1642

[37] Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study [J].

Lee, Mei-Hsuan ;

Yang, Hwai-I. ;

Lu, Sheng-Nan ;

Jen, Chin-Lan ;

You, San-Lin ;

Wang, Li-Yu ;

Wang, Chih-Hao ;

Chen, Wei J. ;

Chen, Chien-Jen .

JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (04) :469-477

[38] Non-genomic loss of PTEN function in cancer: not in my genes [J].

Leslie, Nick R. ;

Foti, Michelangelo .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (03) :131-140

[39] Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly [J].

Li, Qisheng ;

Pene, Veronique ;

Krishnamurthy, Siddharth ;

Cha, Helen ;

Liang, T. Jake .

NATURE MEDICINE, 2013, 19 (06) :722-+

[40] Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3 [J].

Mangia, A ;

Santoro, R ;

Minerva, N ;

Ricci, GL ;

Carretta, V ;

Persico, M ;

Vinelli, F ;

Scotto, G ;

Bacca, D ;

Annese, M ;

Romano, M ;

Zechini, F ;

Sogari, F ;

Spirito, F ;

Andriulli, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (25) :2609-2617

← 1 2 3 4 5 6 7 8 →